The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Bronchospasm - Wheezing - Asthma
Even following topical application of ointment (PMID 29573959). Cross-reacting drugs at PMID 7560658, 24388008
Publications
Nonsteroidal anti-inflammatory drug hypersensitivity in a pediatric severe asthmatic population.
Pediatric pulmonology. 2023;58(10):2983-2986
Risk of Acute Asthma Attacks Associated With Nonsteroidal Anti-inflammatory Drugs: A Self-Controlled Case Series.
Therapeutic innovation & regulatory science. 2017;51(3):332-341
NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity.
Allergy. 2015;70(7):828-35
Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.
The Journal of allergy and clinical immunology. 2014;134(1):40-5
Aspirin and NSAID sensitivity.
Immunology and allergy clinics of North America. 2004;24(3):491-505, vii
The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients.
Thorax. 2002;57(7):569-74
Hypersensitivity to pyrazolones.
Thorax. 2000;55 Suppl 2(Suppl 2):S72-4
Drug-induced attack of bronchial asthma in inpatients: a 20-year survey of the Comprehensive Hospital Drug Monitoring Programme on adverse drug reactions, Berne/St. Gallen.
European journal of clinical pharmacology. 1997;53(1):81-2
Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs. A report from the Spanish System of Pharmacovigilance, including an early analysis of topical and enteric-coated formulations.
European journal of clinical pharmacology. 1994;47(4):297-303
Adverse drug reactions leading to hospital admission.
Drug safety. 1991;6(6):450-9